Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An international panel of experts led by NDORMS researchers has developed a reporting guideline which supports the reporting quality of patent landscapes, ultimately promoting better informed decision-making in technology development and research direction.

Patent landscapes are overviews of the patenting activity in a particular field of technology, locally or globally, and provide unique and valuable insights to government, industry or research leaders.

They help key stakeholders identify new areas for research and development and are used to inform policy discussions, strategic research planning and technology transfer.

With patent landscapes often forming the basis of future research agendas in any given field, and informing next steps in technological investment, it is critical we deliver excellent quality patent landscape articles and reports.

The reporting checklist “Reporting Items for Patent Landscapes” (RIPL), published in Nature Biotechnology, offers a framework for articles published in academic journals through a consensus-based set of minimum criteria to include in patent landscape articles. Not only does RIPL provide straightforward and robust support for authors and editors, but its take-up also aids reproducibility and evidence synthesis.

“We want to improve the reporting of patent landscapes to ensure their societal impact is as significant as it can be. The reporting guidelines we have developed aim to do just that by providing support for authors, reviewers and editors working on patent landscape articles.” says Professor Andrew Carr.

Many patent landscapes are now gaining widespread attention through publication in high-impact journals, but unfortunately recent research showed their reporting to be inadequate.

Professor Carr adds: “In addition to authors and editors using RIPL, journal endorsement of the guidelines would encourage adherence and provide a uniform set of requirements for authors publishing in the field. We hope journals are watching this space.”

Reporting guidelines are commonly used in publications of health and biomedical research, where they have shown to improve reporting quality and ultimately lead to better, more transparent research with greater potential for impact.

The guideline has been registered with the EQUATOR Network, an international initiative that seeks to improve the reliability and value of published health research literature by promoting transparent and accurate reporting and wider use of robust reporting guidelines.

Read the full paper

The Reporting Items for Patent Landscapes statement

Nature Biotechnology volume36pages10431047 (2018)

Similar stories

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).